Tracked claims Linked public records Regulatory actions involving BPC-157 FDA Advisory committee FDA advisory committee to review seven peptide-related bulk drug substances Scheduled Scheduled public meeting FDA scheduled a two-day Pharmacy Compounding Advisory Committee meeting to discuss whether BPC-157, KPV, TB-500, MOTS-c, emideltide/DSIP, Semax, and Epitalon-related substances should be included on the 503A Bulks List
Handling & Storage Guidance Proper handling of bacteriostatic water is essential to maintain sterility and performance throughout its use
Pain may develop suddenly from an injury or can build gradually due to repeated stress on the joint or a degenerative condition
The conversation is no longer just about pushing harder, training longer, or doing more
Such claims, according to the agency, are in violation of the Federal Food, Drug, and Cosmetic Act, which prohibits the sale of unapproved drugs